US 11230544
Substituted 1,3,4-thiadiazoles as GLS1 inhibitors
granted A61KA61K31/337A61K31/555
Quick answer
US patent 11230544 (Substituted 1,3,4-thiadiazoles as GLS1 inhibitors) held by Medshine Discovery Inc. expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/337, A61K31/555, A61K31/704, A61P